@inproceedings{inproceedings, title = {{Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial trapeze trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747).}},
url = {{}},
year = {{2013}},
month = {{5}},
author = {{James ND and Pirrie S and Barton D and Brown JE and Billingham L and Collins SI and Daunton A and Birtle AJ and Chakraborti PR and Ford D and Hussain SA et al}},
volume = {{31}},
journal = {{JOURNAL OF CLINICAL ONCOLOGY}},
issue = {{15}},
note = {{Accessed on 2025/02/12}}}